Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Regulatory Approval
Sort By
Newest First
1 / 1
1 / 1
IND, NDA, and BLA
Building a Regulatory Roadmap for IND, NDA, and BLA
Rebecca Lamb-Wharton, Ph.D.; Brenda Schlenk, RPh; Mamadou Diallo, PharmD
PAO-03-24-CL-10
Mar 26, 2024
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03
Mar 07, 2023
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-01
Mar 07, 2023
New Drug News
New Drug News: Regulatory Approval Brings siRNA into the Rare Disease Toolbox
David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-18-NI-010
Oct 26, 2018
Regulatory
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (daratumumab) Split Dosing Regimen
Janssen Pharmaceutical Companies
PR-M08-18-NI-093
Aug 23, 2018
Drug Approval
Fast Approval for Roche Drug Alecensa in China
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-18-NI-023
Aug 22, 2018
Regulatory
China to Accelerate Review of 48 Foreign Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-18-NI-013
Aug 14, 2018
Biosimilar
European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Amgen
PR-M01-18-NI-077
Jan 24, 2018
EU Approves AstraZeneca’s Respiratory Biologic
Nigel Walker
Nice Insight
PAO-M01-18-NI-031
Jan 18, 2018
Innovation
New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices
Abbott
PR-M01-18-NI-008
Jan 03, 2018
Strategic Partnership
Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma
Nice Insight
PAO-M01-18-NI-002
Jan 02, 2018
